Globus Medical Inc (GMED)
84.91
+1.32
(+1.58%)
USD |
NYSE |
Nov 21, 16:00
84.88
-0.03
(-0.04%)
Pre-Market: 20:00
Globus Medical Enterprise Value: 11.30B for Nov. 21, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 21, 2024 | 11.30B |
| November 20, 2024 | 11.12B |
| November 19, 2024 | 11.09B |
| November 18, 2024 | 10.89B |
| November 15, 2024 | 10.79B |
| November 14, 2024 | 10.79B |
| November 13, 2024 | 10.98B |
| November 12, 2024 | 11.10B |
| November 11, 2024 | 10.91B |
| November 08, 2024 | 10.76B |
| November 07, 2024 | 10.90B |
| November 06, 2024 | 11.00B |
| November 05, 2024 | 10.03B |
| November 04, 2024 | 9.917B |
| November 01, 2024 | 9.939B |
| October 31, 2024 | 9.737B |
| October 30, 2024 | 9.945B |
| October 29, 2024 | 9.839B |
| October 28, 2024 | 9.827B |
| October 25, 2024 | 9.687B |
| October 24, 2024 | 9.750B |
| October 23, 2024 | 9.784B |
| October 22, 2024 | 9.708B |
| October 21, 2024 | 9.730B |
| October 18, 2024 | 9.643B |
| Date | Value |
|---|---|
| October 17, 2024 | 9.788B |
| October 16, 2024 | 9.919B |
| October 15, 2024 | 9.806B |
| October 14, 2024 | 9.417B |
| October 11, 2024 | 9.333B |
| October 10, 2024 | 9.227B |
| October 09, 2024 | 9.316B |
| October 08, 2024 | 9.264B |
| October 07, 2024 | 9.242B |
| October 04, 2024 | 9.345B |
| October 03, 2024 | 9.261B |
| October 02, 2024 | 9.253B |
| October 01, 2024 | 9.310B |
| September 30, 2024 | 9.465B |
| September 27, 2024 | 9.499B |
| September 26, 2024 | 9.486B |
| September 25, 2024 | 9.463B |
| September 24, 2024 | 9.550B |
| September 23, 2024 | 9.581B |
| September 20, 2024 | 9.503B |
| September 19, 2024 | 9.497B |
| September 18, 2024 | 9.361B |
| September 17, 2024 | 9.327B |
| September 16, 2024 | 9.412B |
| September 13, 2024 | 9.382B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
3.189B
Minimum
Mar 16 2020
11.30B
Maximum
Nov 21 2024
6.379B
Average
6.250B
Median
Sep 13 2023
Enterprise Value Benchmarks
| Boston Scientific Corp | 143.48B |
| ResMed Inc | 36.01B |
| Haemonetics Corp | 5.216B |
| Abbott Laboratories | 210.81B |
| Stryker Corp | 159.53B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | 51.84M |
| Revenue (Quarterly) | 625.70M |
| Total Expenses (Quarterly) | 576.71M |
| EPS Diluted (Quarterly) | 0.38 |
| Gross Profit Margin (Quarterly) | 56.77% |
| Profit Margin (Quarterly) | 8.28% |
| Earnings Yield | 0.79% |
| Operating Earnings Yield | 1.45% |
| Normalized Earnings Yield | 1.050 |